150 related articles for article (PubMed ID: 35460603)
1. Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS.
Wang F; Zhao M; Chang B; Zhou Y; Wu X; Ma M; Liu S; Cao Y; Zheng M; Dang Y; Xu J; Chen L; Liu T; Tang F; Ren Y; Xu Z; Mao Z; Huang K; Luo M; Li J; Liu H; Ge B
Mol Cell; 2022 Jun; 82(11):2032-2049.e7. PubMed ID: 35460603
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PARP1 Dampens Pseudorabies Virus Infection through DNA Damage-Induced Antiviral Innate Immunity.
Li GL; Ding GX; Zeng L; Ming SL; Fu PF; Wang Q; Yang GY; Wang J; Chu BB
J Virol; 2021 Jul; 95(16):e0076021. PubMed ID: 34037418
[TBL] [Abstract][Full Text] [Related]
3. Pseudorabies virus usurps non-muscle myosin heavy chain IIA to dampen viral DNA recognition by cGAS for antagonism of host antiviral innate immunity.
Liu Y; Qin Y; Yang B; Zheng H; Qiao S; Luo Z; Li R
J Virol; 2024 May; 98(5):e0048324. PubMed ID: 38639486
[TBL] [Abstract][Full Text] [Related]
4. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.
Liu H; Zhang H; Wu X; Ma D; Wu J; Wang L; Jiang Y; Fei Y; Zhu C; Tan R; Jungblut P; Pei G; Dorhoi A; Yan Q; Zhang F; Zheng R; Liu S; Liang H; Liu Z; Yang H; Chen J; Wang P; Tang T; Peng W; Hu Z; Xu Z; Huang X; Wang J; Li H; Zhou Y; Liu F; Yan D; Kaufmann SHE; Chen C; Mao Z; Ge B
Nature; 2018 Nov; 563(7729):131-136. PubMed ID: 30356214
[TBL] [Abstract][Full Text] [Related]
5. cGAS surveillance of micronuclei links genome instability to innate immunity.
Mackenzie KJ; Carroll P; Martin CA; Murina O; Fluteau A; Simpson DJ; Olova N; Sutcliffe H; Rainger JK; Leitch A; Osborn RT; Wheeler AP; Nowotny M; Gilbert N; Chandra T; Reijns MAM; Jackson AP
Nature; 2017 Aug; 548(7668):461-465. PubMed ID: 28738408
[TBL] [Abstract][Full Text] [Related]
6. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
7. Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin.
Lin S; Tu G; Yu Z; Jiang Q; Zhang L; Liu J; Liu Q; Huang X; Xu J; Lin Y; Liu Y; Wu L
Bioorg Med Chem; 2022 Sep; 70():116912. PubMed ID: 35830778
[TBL] [Abstract][Full Text] [Related]
8. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
9. PARP1 inhibition enhances reactive oxygen species on gut microbiota.
Zhuang Y; Wang H; Ding J; Zhang X; Liu X; Zhang S; Xing X; Kaudimba KK; He M; Zhang S; Guo S; Kong X; Jin L; Liu T
J Cell Physiol; 2022 Nov; 237(11):4169-4179. PubMed ID: 35998296
[TBL] [Abstract][Full Text] [Related]
10. The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells.
Sun H; Liu C; Han F; Lin X; Cao L; Liu C; Ji Q; Cui J; Yao Y; Wang B; Liao Y; Nie H; Zhang Y; Li Y
Cell Death Differ; 2023 Apr; 30(4):922-937. PubMed ID: 36750717
[TBL] [Abstract][Full Text] [Related]
11. SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer.
Wei B; Xu L; Guo W; Wang Y; Wu J; Li X; Cai X; Hu J; Wang M; Xu Q; Liu W; Gu Y
Cancer Res; 2021 Jun; 81(12):3215-3228. PubMed ID: 33820798
[TBL] [Abstract][Full Text] [Related]
12. PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response.
Kim C; Wang XD; Yu Y
Elife; 2020 Aug; 9():. PubMed ID: 32844745
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
15. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
16. High speed of fork progression induces DNA replication stress and genomic instability.
Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
[TBL] [Abstract][Full Text] [Related]
17. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
19. PARP1 associates with R-loops to promote their resolution and genome stability.
Laspata N; Kaur P; Mersaoui SY; Muoio D; Liu ZS; Bannister MH; Nguyen HD; Curry C; Pascal JM; Poirier GG; Wang H; Masson JY; Fouquerel E
Nucleic Acids Res; 2023 Mar; 51(5):2215-2237. PubMed ID: 36794853
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
